News About: Pharm. Industry
Differentiated strategy of domestic pharmaceutical companies to catch Atozet
In the ezetimibe market represented by ‘Vytorin’ and ‘Atozet,’ domestic pharmaceutical companies have gotten ready to enter.
The pharmaceutical companies have tried to attract interests of the market by differentiati...
Novartis Korea increases distribution margins under collection conditionWhile some multinational pharmaceutical companies are in confrontation with the pharmaceutical distribution industry due to low margins, Novartis Korea has increased distributio...
|
Chong Kun Dang and Hanmi to take leads in patent challengesChong Kun Dang and Hanmi Pharm have taken leads of other domestic pharmaceutical companies not only business competition, but patent challenges which is a starting point of gene...
|
Pharmaceutical companies concerning about Wage Peak System
While the Wage Peak System has become a topic to talk about among private companies as the government has pushed forward with the system to make job creation for the young and stable employment, the pharmaceutical ind...
Boehringer Ingelheim Korea appointed Gi-hwan Park as new CEO
Mr. Gi-hwan Park has been appointed as the new CEO of Boehringer Ingelheim Korea.
Boehringer Ingelheim Korea announced the appointment of Mr. Gi-hwan Park(51) as a new CEO from the 21st of September. The new CEO, Gi-...
Hanmi Pharm close to commercialize new once-month administration diabetes drugPossibility to develop the once-monthly administration for a new GLP-1 diabetes drug(efpeglenatide), developed by Hanmi Pharm, has been confirmed once again.
Hanmi Pharm(CEO Kw...
|
Pfizer enlarges market defense position through high-volume CelebrexPfizer Korea has targeted generics of Celebrex(celecoxib), a blockbuster treatment, by volume diversification. Its high-volume 400mg product has been newly approved, and the 100...
|
Leaderships of the Samsung’s biopharmaceutical business, Han-seung Ko and Tae-han Kim
Samsung Bioepis and Samsung Biologics are observed to successfully settle down in the market in 4 years of their launches.
Samsung selected biopharmaceutical as one of the top 5 new growth powers along with LED(light...
Female employees of listed pharmaceutical companies to earn only 70% of male annual wages
It was observed that while the average annual wage of listed pharmaceutical companies’ employees was KRW 50 million, annual wages of female employees were only 70% of the ones of male employees.
According to the Yaku...
Pharmaceutical companies push all-in for new businesses
“We must secure competitiveness through new businesses.”
Expansion of domestic md-sized pharmaceutical companies’ new business has become a clear point to keep an eye on.
Medium pharmaceutical companies focusing on ...
